Local control with conventional and hypofractionated adjuvant radiotherapy after breast-conserving surgery for ductal carcinoma in-situ

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 317-320

  Williamson, Deborah ^a   Dinniwell, Robert ^a   Fung, Sharon ^a   Pintilie, Melania ^a   Done, Susan J ^b   Fyles, Anthony W ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Ductal carcinoma in situ; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST NECROSIS; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 77952586025     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.03.021     Document Type: Article

References (25)

1. Ernster V.L., Ballard-Barbash R., Barlow W.E., et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94 (2002) 1546
2. Canada H. Organized Breast Cancer Screening Programs in Canada, 2001 and 2002 Report. 2005.
3. Dodwell D., Clements K., Lawrence G., et al. Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project. Br J Cancer 97 (2007) 725-729
4. Levi F., Te V.C., Randimbison L., et al. Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer 33 (1997) 903-906
5. Kricker A., Goumas C., and Armstrong B. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. Br J Cancer 90 (2004) 1382-1385
6. Burstein H.J., Polyak K., Wong J.S., et al. Ductal carcinoma in situ of the breast. N Engl J Med 350 (2004) 1430-1441
7. Olivotto I.A., Bancej C., Goel V., et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 165 (2001) 277-283
8. Houghton J., George W.D., Cuzick J., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362 (2003) 95-102
9. Julien J.P., Bijker N., Fentiman I.S., et al. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355 (2000) 528-533
10. Fisher B., Dignam J., Wolmark N., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 (1998) 441-452
11. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
12. Whelan T., Pignol J.P., Levine M., et al. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. N Engl J Med 11 (2010) 513-520
13. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 (2008) 1098-1107
14. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996) 1659-1664
15. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351 (2004) 963-970
16. Viani G.A., Stefano E.J., Afonso S.L., et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2 (2007) 28
17. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467
18. Yarnold J., Ashton A., Bliss J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
19. Meijnen P., Oldenburg H.S., Peterse J.L., et al. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 15 (2008) 235-243
20. Sahoo S., Recant W.M., Jaskowiak N., et al. Defining negative margins in DCIS patients treated with breast conservation therapy: the University of Chicago experience. Breast J 11 (2005) 242-247
21. Dunne C., Burke J.P., Morrow M., et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27 (2009) 1615-1620
22. Bijker N., Meijnen P., Peterse J.L., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 (2006) 3381-3387
23. Ringberg A., Nordgren H., Thorstensson S., et al. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - results from the Swedish randomised trial. Eur J Cancer 43 (2007) 291-298
24. Rakovitch E., Pignol J.P., Hanna W., et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol 25 (2007) 5591-5596
25. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265